5-161331058-T-C
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The NM_001371727.1(GABRB2):c.902A>G(p.Tyr301Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y301F) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001371727.1 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy 92Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Illumina, G2P
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001371727.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GABRB2 | NM_001371727.1 | MANE Select | c.902A>G | p.Tyr301Cys | missense | Exon 8 of 10 | NP_001358656.1 | ||
| GABRB2 | NM_021911.3 | c.902A>G | p.Tyr301Cys | missense | Exon 9 of 11 | NP_068711.1 | |||
| GABRB2 | NM_000813.3 | c.902A>G | p.Tyr301Cys | missense | Exon 9 of 10 | NP_000804.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GABRB2 | ENST00000393959.6 | TSL:1 MANE Select | c.902A>G | p.Tyr301Cys | missense | Exon 8 of 10 | ENSP00000377531.1 | ||
| GABRB2 | ENST00000353437.10 | TSL:1 | c.902A>G | p.Tyr301Cys | missense | Exon 9 of 10 | ENSP00000274546.6 | ||
| GABRB2 | ENST00000520240.5 | TSL:1 | c.902A>G | p.Tyr301Cys | missense | Exon 9 of 10 | ENSP00000429320.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 35718920, 31036916, 31785789, 33057194, 35982159)
Intellectual disability Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 301 of the GABRB2 protein (p.Tyr301Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of GABRB2-related conditions (PMID: 31036916, 31785789; Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 421234). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GABRB2 protein function.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at